Non-profit · founded 1943
Vitalant
Denver, United States · vitalant.org/Locations2/Colorado/Denver-West-donation-center.aspx
Part of Vitalant
- Citations, last 5 years
- 785
- Works, last 5 years
- 174
- h-index
- 36
- Scientists listed
- 7
- Grants since 2016
- 77
Grants received
2025–2027 · research · R21
Defining Drivers of mtDNA Levels in Blood Components and Their Impact on Transfusion-Related Lung Injury
Philip J. Norris · Vitalant · funded by National Institutes of Health
2025–2029 · research · R01
Leveraging Stored Platelet Bioenergetics to Improve Hemostatic Function Upon Transfusion
Kimberly Anne Thomas · Vitalant · funded by National Institutes of Health
2024–2029 · research · R01
Modulation of Galectin-9 to Target HIV Persistence
Lishomwa C Ndhlovu · Vitalant · funded by National Institutes of Health
2024
Enhancing anti-HIV gene therapy through epigenetic modulation
Mohamed Bouzidi · Vitalant · funded by Office of the President, University of California
2024–2026 · contract · N01
REDS-IV-P DOMESTIC HUBS
Brian Custer · Vitalant · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic Response
Michael Paul Busch · Vitalant · funded by Centers for Disease Control and Prevention
2024–2026 · research · R21
Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository
Michael Paul Busch · Vitalant · funded by National Institutes of Health
2024–2026 · contract · N01
REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES
Philip J. Norris · Vitalant · funded by National Institutes of Health
2024–2029 · grant · DP1
Extracellular Vesicles as Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Disease in Persons Living with HIV
Erika Grasiela Marques De Menezes · Vitalant · funded by National Institutes of Health
2024–2026 · research · R21
Possible transfusion transmitted cerebral amyloid angiopathy: evaluation of transmission of Aβ using the RADAR repository
Michael Paul Busch · Vitalant · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
RFA-IP-24-046: Nationwide Cohort of Blood Donors to Estimate Burden of Respiratory Viruses and Immunologic Response
Michael Paul Busch · Vitalant · funded by Centers for Disease Control and Prevention
2024–2029 · research · R01
Modulation of Galectin-9 to Target HIV Persistence
Lishomwa C Ndhlovu · Vitalant · funded by National Institutes of Health
2024–2029 · grant · DP1
Extracellular Vesicles as Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Disease in Persons Living with HIV
Erika Grasiela Marques De Menezes · Vitalant · funded by National Institutes of Health
2023–2027 · research · R01
Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo
Satish Kumar Pillai · Vitalant · funded by National Institutes of Health
2023–2027 · research · R01
Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo
Satish Kumar Pillai · Vitalant · funded by National Institutes of Health
2023–2027 · research · R01
Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo
Satish Kumar Pillai · Vitalant · funded by National Institutes of Health
2022–2023 · research · R56
Innate Sensing of Cell-Free DNA and the Interferon-Mediated Control of HIV In Vivo
Satish Kumar Pillai · Vitalant · funded by National Institutes of Health
2022–2027 · research · R01
Hematopoietic and Immune Development in the Human Chorion
Marcus O Muench · Vitalant · funded by National Institutes of Health
2022–2027 · research · R01
Hematopoietic and Immune Development in the Human Chorion
Marcus O Muench · Vitalant · funded by National Institutes of Health
2022–2027 · research · R01
Hematopoietic and Immune Development in the Human Chorion
Marcus O Muench · Vitalant · funded by National Institutes of Health
2022–2027 · research · R01
Hematopoietic and Immune Development in the Human Chorion
Marcus O Muench · Vitalant · funded by National Institutes of Health
2021–2024 · contract · N01
REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2
Philip J. Norris · Vitalant · funded by National Institutes of Health
2021–2024 · contract · N01
REDS-IV-P DOMESTIC HUBS PHASE 2
Brian Custer · Vitalant · funded by National Institutes of Health
2021–2024 · contract · N01
REDS-IV-P BRAZIL TRANSFUSION SAFETY RESEARCH PROGRAM PHASE 2
Brian Custer · Vitalant · funded by National Institutes of Health
2021–2024 · contract · N01
REDS-IV-P BRAZIL TRANSFUSION SAFETY RESEARCH PROGRAM PHASE 2
Brian Custer · Vitalant · funded by National Institutes of Health
2021–2024 · contract · N01
REDS-IV-P CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) PHASE 2
Philip J. Norris · Vitalant · funded by National Institutes of Health
2021–2024 · contract · N01
REDS-IV-P DOMESTIC HUBS PHASE 2
Brian Custer · Vitalant · funded by National Institutes of Health
2020–2024 · research · R01
Transfusion-related immunomodulation influences infectious disease outcomes
Graham Simmons · Vitalant · funded by National Institutes of Health
2020–2025 · research · R01
Transfusion-related immunomodulation influences infectious disease outcomes
Graham Simmons · Vitalant · funded by National Institutes of Health
2020–2024 · research · R01
Transfusion-related immunomodulation influences infectious disease outcomes
Graham Simmons · Vitalant · funded by National Institutes of Health
2020–2024 · research · R01
Transfusion-related immunomodulation influences infectious disease outcomes
Graham Simmons · Vitalant · funded by National Institutes of Health
2019–2024 · research · R01
The impact of illness and medical treatments on the alloantibody response to platelet transfusion
Rachael Peretz Jackman · Vitalant · funded by National Institutes of Health
2019–2023 · research · R01
The impact of illness and medical treatments on the alloantibody response to platelet transfusion
Rachael Peretz Jackman · Vitalant · funded by National Institutes of Health
2019–2021 · contract · N01
(REDS-IV-P) RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY IV-DOMESTIC HUBS
Brian Custer · Vitalant · funded by National Institutes of Health
2019–2023 · research · R01
The impact of illness and medical treatments on the alloantibody response to platelet transfusion
Rachael Peretz Jackman · Vitalant · funded by National Institutes of Health
2019–2021 · contract · N01
REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) - SARS-CoV-2/COVID-19 STUDIES
Michael Paul Busch · Vitalant · funded by National Institutes of Health
2019–2023 · research · R01
The impact of illness and medical treatments on the alloantibody response to platelet transfusion
Rachael Peretz Jackman · Vitalant · funded by National Institutes of Health
2019–2021 · contract · N01
REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS), PHASE 1.
Michael Paul Busch · Vitalant · funded by National Institutes of Health
2019–2021 · contract · N01
REDS-IV-P BRAZIL PHASE 1
Brian Custer · Vitalant · funded by National Institutes of Health
2018–2022 · research · R01
Effect of blood donor sex and testosterone on predisposition to hemolysis in stored red blood cells
Tamir Kanias · Vitalant · funded by National Institutes of Health